# Pharmacodynamic Clinical Trial of Cardiovascular Polypill on LDL Cholesterol

Study · id `cardio:ct-nct01362218` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01362218](<https://clinicaltrials.gov/study/NCT01362218>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01362218

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 107 participants.

## Technical summary

Registry record NCT01362218. Randomized; no masking; primary purpose prevention. Start 2010-10 (registry gives no type); primary completion 2012-04 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 2
- Enrolled: 107 participants (enrolled count; ClinicalTrials.gov record NCT01362218, source copy `cardio:ctgov-nct01362218-2013-04-24`, retrieved 2026-10-31)
- Start date: 2010-10 (registry gives no type) (ClinicalTrials.gov record NCT01362218, source copy `cardio:ctgov-nct01362218-2013-04-24`, retrieved 2026-10-31)
- Primary completion: 2012-04 (actual) (ClinicalTrials.gov record NCT01362218, source copy `cardio:ctgov-nct01362218-2013-04-24`, retrieved 2026-10-31)
- Completion: 2012-04 (actual) (ClinicalTrials.gov record NCT01362218, source copy `cardio:ctgov-nct01362218-2013-04-24`, retrieved 2026-10-31)
- Countries: Spain (ClinicalTrials.gov record NCT01362218, source copy `cardio:ctgov-nct01362218-2013-04-24`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01362218-2013-04-24`, retrieved 2026-10-31)

## The registry's words

- Brief title: Pharmacodynamic Clinical Trial of Cardiovascular Polypill on LDL Cholesterol
- Condition: Elevated LDL Cholesterol
- Intervention (Drug): Cardiovascular fixed dose combination pill (acetylsalicylic acid, simvastatin and ramipril)
- Intervention (Drug): Simvastatin, ramipril, acetylsalicylic acid
- Lead sponsor: Ferrer Internacional S.A.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry lists this organization as the lead sponsor: Ferrer Internacional S.A. (`cardio:org-ferrer-internacional-s-a`)

## Provenance

Content hash: fded7437983e9cb24c67a820fe4f2c745065cf0058c09896f50b20052ef17519
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
